We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at ...

Here's our initial take on Doximity's (NYSE: DOCS) financial report. Key Metrics Metric Q4 2024 Q4 2025 Change vs.

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, ...

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

Healthcare professional network Doximity (NYSE:DOCS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 17.1% year on year to $138.3 million. On the other hand, next quarter’s ...

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Q4 Adjusted EPS: 31 cents, versus estimates of 27 cents Total revenue climbed 17% year-over-year. Subscription revenue was also up 17%, totaling $131.9 million in the quarter. The company reported ...

Digital medical platform leader Doximity reported better-than-expected results on the top and bottom lines. Free cash flow grew by more than 50% year over year, and margins are stellar.